Showing results (141-150 of 227) with videos related to

Sort By:
Pageof 23
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 23, 1998
Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patientsD Praticò, E Rossi, M Merli, et al.
Nature Medicine|October 15, 1998
Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient miceD Praticò, R K Tangirala, D J Rader, et al.
The Journal of Biological Chemistry|January 25, 2000
Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acidA Burke, J A Lawson, E A Meagher, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interactionD M Kerins, M Shuh, S Kunitada, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 5, 1998
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivoD Praticò, V MY Lee, J Q Trojanowski, et al.
Molecular Biosystems|April 25, 2015
A metabolomic study of adipose tissue in mice with a disruption of the circadian systemC Castro, W Briggs, G K Paschos, et al.
Annals of the New York Academy of Sciences|April 18, 1994
Cellular activation of thromboxane receptorsB T Kinsella, D O'Mahony, J A Lawson, et al.
Annals of Internal Medicine|September 1, 1981
Intravenous prostacyclin in thrombotic thrombocytopenic purpuraG A Fitzgerald, R L Maas, R Stein, et al.
The Journal of Clinical Investigation|February 1, 1986
Estimated rate of thromboxane secretion into the circulation of normal humansC Patrono, G Ciabattoni, F Pugliese, et al.
The Journal of Biological Chemistry|August 26, 1998
Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathwaysP Kunapuli, J A Lawson, J A Rokach, et al.
Pageof 23